Literature DB >> 19393027

Delayed cerebral oxidative glucose metabolism after traumatic brain injury in young rats.

Susanna Scafidi1, Janet O'Brien, Irene Hopkins, Courtney Robertson, Gary Fiskum, Mary McKenna.   

Abstract

Traumatic brain injury (TBI) results in a cerebral metabolic crisis that contributes to poor neurologic outcome. The aim of this study was to characterize changes in oxidative glucose metabolism in early periods after injury in the brains of immature animals. At 5 h after controlled cortical impact TBI or sham surgery to the left cortex, 21-22 day old rats were injected intraperitoneally with [1,6-13C]glucose and brains removed 15, 30 and 60 min later and studied by ex vivo 13C-NMR spectroscopy. Oxidative metabolism, determined by incorporation of 13C into glutamate, glutamine and GABA over 15-60 min, was significantly delayed in both hemispheres of brain from TBI rats. The most striking delay was in labeling of the C4 position of glutamate from neuronal metabolism of glucose in the injured, ipsilateral hemisphere which peaked at 60 min, compared with the contralateral and sham-operated brains, where metabolism peaked at 30 and 15 min, respectively. Our findings indicate that (i) neuronal-specific oxidative metabolism of glucose at 5-6 h after TBI is delayed in both injured and contralateral sides compared with sham brain; (ii) labeling from metabolism of glucose via the pyruvate carboxylase pathway in astrocytes was also initially delayed in both sides of TBI brain compared with sham brain; (iii) despite this delayed incorporation, at 6 h after TBI, both sides of the brain showed apparent increased neuronal and glial metabolism, reflecting accumulation of labeled metabolites, suggesting impaired malate aspartate shuttle activity. The presence of delayed metabolism, followed by accumulation of labeled compounds is evidence of severe alterations in homeostasis that could impair mitochondrial metabolism in both ipsilateral and contralateral sides of brain after TBI. However, ongoing oxidative metabolism in mitochondria in injured brain suggests that there is a window of opportunity for therapeutic intervention up to at least 6 h after injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393027      PMCID: PMC2692097          DOI: 10.1111/j.1471-4159.2009.05896.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  43 in total

Review 1.  Epidemiology and outcomes of pediatric traumatic brain injury.

Authors:  Heather T Keenan; Susan L Bratton
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

Review 2.  The potential role of mitochondria in pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Lucian Soane; Zachary T Siegel; Gary Fiskum
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

3.  Gel-based hippocampal proteomic analysis 2 weeks following traumatic brain injury to immature rats using controlled cortical impact.

Authors:  Ashley R Kochanek; Anthony E Kline; Wei-Min Gao; Mandeep Chadha; Yichen Lai; Robert S B Clark; C Edward Dixon; Larry W Jenkins
Journal:  Dev Neurosci       Date:  2006       Impact factor: 2.984

4.  Hyperoxic reperfusion after global ischemia decreases hippocampal energy metabolism.

Authors:  Erica M Richards; Gary Fiskum; Robert E Rosenthal; Irene Hopkins; Mary C McKenna
Journal:  Stroke       Date:  2007-04-05       Impact factor: 7.914

Review 5.  Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools.

Authors:  Mary C McKenna; Helle S Waagepetersen; Arne Schousboe; Ursula Sonnewald
Journal:  Biochem Pharmacol       Date:  2005-12-20       Impact factor: 5.858

Review 6.  Astrocyte control of synaptic transmission and neurovascular coupling.

Authors:  Philip G Haydon; Giorgio Carmignoto
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

7.  NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat.

Authors:  Chunlong Zhong; Xueren Zhao; Ken C Van; Tomasz Bzdega; Aoife Smyth; Jia Zhou; Alan P Kozikowski; Jiyao Jiang; William T O'Connor; Robert F Berman; Joseph H Neale; Bruce G Lyeth
Journal:  J Neurochem       Date:  2006-04-05       Impact factor: 5.372

8.  Neuroglial metabolism in the awake rat brain: CO2 fixation increases with brain activity.

Authors:  Gülin Oz; Deborah A Berkich; Pierre-Gilles Henry; Yuping Xu; Kathryn LaNoue; Susan M Hutson; Rolf Gruetter
Journal:  J Neurosci       Date:  2004-12-15       Impact factor: 6.167

9.  Upregulation of pentose phosphate pathway and preservation of tricarboxylic acid cycle flux after experimental brain injury.

Authors:  Brenda L Bartnik; Richard L Sutton; Masamichi Fukushima; Neil G Harris; David A Hovda; Stefan M Lee
Journal:  J Neurotrauma       Date:  2005-10       Impact factor: 5.269

10.  Energy sources for glutamate neurotransmission in the retina: absence of the aspartate/glutamate carrier produces reliance on glycolysis in glia.

Authors:  Y Xu; M S Ola; D A Berkich; T W Gardner; A J Barber; F Palmieri; S M Hutson; K F LaNoue
Journal:  J Neurochem       Date:  2007-04       Impact factor: 5.372

View more
  35 in total

1.  Ketogenic diet prevents alterations in brain metabolism in young but not adult rats after traumatic brain injury.

Authors:  Ying Deng-Bryant; Mayumi L Prins; David A Hovda; Neil G Harris
Journal:  J Neurotrauma       Date:  2011-08-04       Impact factor: 5.269

2.  Traumatically injured astrocytes release a proteomic signature modulated by STAT3-dependent cell survival.

Authors:  Jaclynn Levine; Eunice Kwon; Pablo Paez; Weihong Yan; Gregg Czerwieniec; Joseph A Loo; Michael V Sofroniew; Ina-Beate Wanner
Journal:  Glia       Date:  2015-12-19       Impact factor: 7.452

3.  Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain.

Authors:  Susanna Scafidi; Gary Fiskum; Steven L Lindauer; Penelope Bamford; Da Shi; Irene Hopkins; Mary C McKenna
Journal:  J Neurochem       Date:  2010-05-13       Impact factor: 5.372

Review 4.  L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.

Authors:  Gustavo C Ferreira; Mary C McKenna
Journal:  Neurochem Res       Date:  2017-05-16       Impact factor: 3.996

Review 5.  Hemorrhagic progression of a contusion after traumatic brain injury: a review.

Authors:  David Kurland; Caron Hong; Bizhan Aarabi; Volodymyr Gerzanich; J Marc Simard
Journal:  J Neurotrauma       Date:  2011-12-05       Impact factor: 5.269

6.  Alterations in cerebral oxidative metabolism following traumatic brain injury.

Authors:  Michael De Fazio; Richard Rammo; Kristine O'Phelan; M Ross Bullock
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

Review 7.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

8.  Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury.

Authors:  David Tweedie; Lital Rachmany; Vardit Rubovitch; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Barry J Hoffer; Chaim G Pick; Nigel H Greig
Journal:  Neurobiol Dis       Date:  2013-02-27       Impact factor: 5.996

9.  Brain metabolism is significantly impaired at blood glucose below 6 mM and brain glucose below 1 mM in patients with severe traumatic brain injury.

Authors:  Roman Meierhans; Markus Béchir; Silke Ludwig; Jutta Sommerfeld; Giovanna Brandi; Christoph Haberthür; Reto Stocker; John F Stover
Journal:  Crit Care       Date:  2010-02-08       Impact factor: 9.097

Review 10.  Sex differences in pediatric traumatic brain injury.

Authors:  Sheryl E Arambula; Erin L Reinl; Nagat El Demerdash; Margaret M McCarthy; Courtney L Robertson
Journal:  Exp Neurol       Date:  2019-03-02       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.